MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma

被引:13
|
作者
Li, Hai Ming [1 ,2 ]
Qiang, Jin Wei [1 ]
Xia, Gan Lin [2 ]
Zhao, Shu Hui [3 ]
Ma, Feng Hua [1 ]
Cai, Song Qi [1 ]
Feng, Feng [2 ]
Fu, Ai Yan [2 ]
机构
[1] Fudan Univ, Jinshan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 201508, Peoples R China
[2] Nantong Univ, Nantong Canc Hosp, Dept Radiol, Nantong 226361, Jiangsu, Peoples R China
[3] Jiaotong Univ, Xinhua Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 200092, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Ovary; Endometroid carcinoma; High-grade serous carcinoma; Magnetic resonance imaging; Diffusion-weighted imaging; FERTILITY-SPARING SURGERY; YOUNG-WOMEN; CANCER; NEOPLASMS; SUBTYPES;
D O I
10.1186/s13048-015-0154-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To investigate magnetic resonance imaging (MRI) features for differentiating ovarian endometrioid adenocarcinoma (OEC) from high-grade serous adenocarcinoma (HGSC). Materials and methods: Twenty-three patients with 25 OECs and 93 patients with 139 HGSCs confirmed by surgery and pathology underwent conventional MRI and diffusion-weighted imaging (DWI). The MRI features of the tumors, including laterality, size, shape, configuration, signal intensity, ADC value of solid component, enhancement, ascites, synchronous primary cancer (SPC) of the ovary and endometrium, and clinical stage, were evaluated and compared between two groups. Results: The following characteristics were significantly more common for OECs than HGSCs: unilateral (91.3% vs 50.5%, P < 0.001), larger mass (80.0% vs 48.2%, P = 0.005), round or oval shape (64.0% vs 17.3%, P < 0.001), mainly cystic with mural nodules or papillary projections (72.0% vs 18.7%, P < 0.001), cystic component with homogeneous iso-or hyperintensity on T1WI (82.6% vs 4.3%, P < 0.001), moderate enhancement (52.0% vs 26.6%, P = 0.011), no or mild ascites (91.3% vs 57.0%, P = 0.002), and SPC (43.5% vs 4.3%, P < 0.001). The ADC value of the solid component was higher in OECs (0.979 +/- 0.197 x 10(-3) mm(2)/s) than in HGSCs (0.820 +/- 0.112 x 10(-3) mm(2)/s) (P = 0.002). When a mainly cystic mass with mural nodules or papillary projections was associated with any one of homogeneously iso-or hyperintense cystic component on TIWI, a relatively higher ADC value and SPC, the sensitivity, specificity, accuracy, and positive and negative predictive values for characterizing OEC were 87.0%, 93.5%, 92.2%, 76.9%, and 96.7%, respectively. Conclusions: Conventional MRI combining DWI is helpful for differentiating OECs from HGSCs.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The Changing View of High-Grade Serous Ovarian Cancer
    Berns, Els M. J. J.
    Bowtell, David D.
    CANCER RESEARCH, 2012, 72 (11) : 2701 - 2704
  • [42] The genesis and evolution of high-grade serous ovarian cancer
    David D. L. Bowtell
    Nature Reviews Cancer, 2010, 10 : 803 - 808
  • [43] Personalising Treatment for High-Grade Serous Ovarian Carcinoma
    Cojocaru, E.
    Parkinson, C. A.
    Brenton, J. D.
    CLINICAL ONCOLOGY, 2018, 30 (08) : 515 - 524
  • [44] The genesis and evolution of high-grade serous ovarian cancer
    Bowtell, David D. L.
    NATURE REVIEWS CANCER, 2010, 10 (11) : 803 - 808
  • [45] Proteogenomic characterization of high-grade serous ovarian cancer
    McDermott, Jason E.
    Payne, Samuel
    Ray, Debjit
    Petyuk, Vladislav
    Moore, Ronald
    Gritsenko, Marina
    Smith, Richard
    Rodland, Karin
    CANCER RESEARCH, 2016, 76
  • [46] Cell Origins of High-Grade Serous Ovarian Cancer
    Kim, Jaeyeon
    Park, Eun Young
    Kim, Olga
    Schilder, Jeanne M.
    Coffey, Donna M.
    Cho, Chi-Heum
    Bast, Robert C., Jr.
    CANCERS, 2018, 10 (11)
  • [47] A clinicopathological study of ovarian high-grade serous carcinomas
    Popa, M.
    Comanescu, M.
    Poteca, A.
    Mehotin, C.
    Andrei, F.
    VIRCHOWS ARCHIV, 2016, 469 : S278 - S278
  • [48] COMBINED HIGH-GRADE SARCOMA AND SEROUS OVARIAN NEOPLASM
    ALLEN, C
    STEPHENS, M
    WILLIAMS, J
    JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (03) : 263 - 264
  • [49] High-grade serous ovarian cancer: the clone wars
    Aleksander Salomon-Perzyński
    Magdalena Salomon-Perzyńska
    Bogdan Michalski
    Violetta Skrzypulec-Plinta
    Archives of Gynecology and Obstetrics, 2017, 295 : 569 - 576
  • [50] The role of Apela in high-grade serous ovarian cancer
    Daily, Laura R.
    Ganguly, Debolina
    Hayes, D. Neil
    Wang, Yinan
    Sims, Michelle M.
    Cheng, Jinjun
    ElNaggar, Adam C.
    Pfeffer, Lawrence M.
    CANCER RESEARCH, 2018, 78 (13)